Senior Management

Learn More

Board of Directors

Learn More

Clinical Advisory Board

Learn More

Scientific Advisory Board

Learn More

Bexion Milestones

Bexion at a glance data

Making Significant Progress

Bexion at a glance data

Bexion Media

PRESS RELEASE

Bexion Pharmaceuticals, Inc. Receives Rare Pediatric Disease Designation
September 30, 2020

FOR IMMEDIATE RELEASE [Covington, KY] September 30, 2020 Bexion Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing innovative cures for cancer, announced that the Federal Drug Administration (FDA) has granted the company’s request for rare pediatric disease designation for BXQ-350, Bexion’s lead therapeutic, for the treatment of diffuse intrinsic pontine glioma (DIPG) and […]

read more
All Press


Cincinnati Enquirer: 8 Cincinnati biotech companies with big steps to watch in 2020
January 1, 2020

read more
Bexion In the News